Trust Point’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$575K Buy
2,195
+634
+41% +$167K 0.04% 233
2026
Q2
$345K Buy
1,561
+432
+38% +$120K 0.03% 308
2026
Q1
$333K Buy
1,129
+122
+12% +$36.2K 0.03% 356
2025
Q4
$275K Buy
1,007
+99
+11% +$26.9K 0.02% 390
2025
Q3
$245K Buy
+908
New +$247K 0.02% 414
2025
Q1
– Sell
-1,021
Closed -$237K – 475
2024
Q4
$237K Buy
1,021
+72
+8% +$16.6K 0.02% 496
2024
Q3
$209K Buy
+949
New +$196K 0.02% 493
2024
Q2
– Sell
-1,267
Closed -$273K – 504
2024
Q1
$273K Sell
1,267
-2,302
-64% -$484K 0.02% 430
2023
Q4
$752K Buy
+3,569
New +$762K 0.06% 178

Other funds holding CME

Trust Point's CME Position: Q3 2026 in Review

Trust Point increased its CME Group (CME) stake by 41% in Q3 2026, buying an estimated $167K and bringing the position to 2,195 shares worth $575K. The position accounts for 0.04% of the portfolio, ranked #233.

Trust Point first reported a position in CME in Q4 2023 and has held it in 9 quarters since. The position peaked at $752K in Q4 2023. 1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Trust Point held 2,195 shares of CME Group worth $575K as of Q3 2026.
  • Trust Point bought 634 CME Group shares in Q3 2026, an estimated $167K.
  • CME Group made up 0.04% of Trust Point's portfolio in Q3 2026, its #233 holding.
  • Trust Point first reported a position in CME Group in Q4 2023 and has held it in 9 quarters since.
  • Trust Point's CME Group position peaked at $752K in Q4 2023.
  • 1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.